Rad9 Antibodies

Santa Cruz Biotechnology provides a broad selection of Rad9 Antibodies for research in cell cycle regulation and DNA damage response. Monoclonal Rad9 Antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Rad9 is a crucial component of the DNA damage checkpoint pathway, playing a significant role in maintaining genomic stability and facilitating DNA repair processes. The function of Rad9 is vital for the proper response to DNA damage, which can prevent the development of cancer and other diseases. The study of Rad9 and its interactions provides insights into the mechanisms of tumorigenesis and the cellular response to genotoxic stress. Understanding Rad9 function helps researchers explore new therapeutic strategies for cancer treatment. Investigating Rad9 pathways reveals important mechanisms in cell cycle control and genome maintenance. Santa Cruz Biotechnology monoclonal Rad9 Antibodies enable researchers to advance their understanding of DNA damage response mechanisms and contribute to breakthroughs in cancer research and therapeutic development.